Hava Shapiro

998 total citations
34 papers, 808 citations indexed

About

Hava Shapiro is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Hava Shapiro has authored 34 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Hematology and 8 papers in Genetics. Recurrent topics in Hava Shapiro's work include Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Platelet Disorders and Treatments (4 papers). Hava Shapiro is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Platelet Disorders and Treatments (4 papers). Hava Shapiro collaborates with scholars based in Israel, United States and Poland. Hava Shapiro's co-authors include Judith Radnay, Michael Lishner, Liat Drucker, Shabtai Varsano, Dov Ophir, Yoram Neuman, Simcha Meisel, Nachman Gruener, Shai Yarkoni and Martin Ellis and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Cancer.

In The Last Decade

Hava Shapiro

34 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hava Shapiro Israel 17 244 197 184 169 138 34 808
Leslie Oleksowicz United States 17 138 0.6× 292 1.5× 236 1.3× 195 1.2× 54 0.4× 35 780
José G. van den Berg Netherlands 14 191 0.8× 103 0.5× 196 1.1× 133 0.8× 105 0.8× 36 968
Beate M. Rüger Austria 16 225 0.9× 87 0.4× 181 1.0× 318 1.9× 233 1.7× 28 970
Tsukasa Takemura Japan 20 322 1.3× 124 0.6× 71 0.4× 203 1.2× 118 0.9× 55 1.1k
Thomas Karonitsch Austria 19 236 1.0× 142 0.7× 151 0.8× 355 2.1× 69 0.5× 41 984
H. Karel Nieuwenhuis Netherlands 12 213 0.9× 611 3.1× 147 0.8× 130 0.8× 123 0.9× 14 1.2k
Jie Ding China 16 604 2.5× 115 0.6× 205 1.1× 197 1.2× 108 0.8× 57 1.2k
Noreen Fulton United States 20 457 1.9× 225 1.1× 460 2.5× 124 0.7× 192 1.4× 42 1.2k
Maria Melachrinou Greece 17 231 0.9× 52 0.3× 166 0.9× 118 0.7× 123 0.9× 54 722
Boting Wu China 15 199 0.8× 141 0.7× 158 0.9× 130 0.8× 76 0.6× 47 768

Countries citing papers authored by Hava Shapiro

Since Specialization
Citations

This map shows the geographic impact of Hava Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hava Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hava Shapiro more than expected).

Fields of papers citing papers by Hava Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hava Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hava Shapiro. The network helps show where Hava Shapiro may publish in the future.

Co-authorship network of co-authors of Hava Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Hava Shapiro. A scholar is included among the top collaborators of Hava Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hava Shapiro. Hava Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briscoe, Daniel, et al.. (2017). Characteristics of orbital lymphoma: a clinicopathological study of 26 cases. International Ophthalmology. 38(1). 271–277. 15 indexed citations
2.
Zismanov, Victoria, Michael Lishner, Shelly Tartakover‐Matalon, et al.. (2009). Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling. British Journal of Cancer. 101(8). 1402–1409. 38 indexed citations
3.
Gronich, Naomi, Judith Radnay, Hava Shapiro, et al.. (2007). Clinical outcome of low‐grade NHL patients with bone marrow involvement. European Journal of Clinical Investigation. 37(4). 305–309. 9 indexed citations
4.
Elis, Avishay, et al.. (2006). Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?. PubMed. 8(12). 840–2. 1 indexed citations
5.
Drucker, Liat, Shelly Tartakover‐Matalon, Victoria Zismanov, et al.. (2005). Promoter hypermethylation of tetraspanin members contributes to their silencing in myeloma cell lines. Carcinogenesis. 27(2). 197–204. 37 indexed citations
6.
Lahav, Meir, Orit Uziel, Meir Kestenbaum, et al.. (2005). Nonmyeloablative Conditioning Does Not Prevent Telomere Shortening after Allogeneic Stem Cell Transplantation. Transplantation. 80(7). 969–976. 23 indexed citations
7.
Gronich, Naomi, Liat Drucker, Hava Shapiro, et al.. (2004). Simvastatin Induces Death of Multiple Myeloma Cell Lines. Journal of Investigative Medicine. 52(5). 335–344. 32 indexed citations
8.
Radnay, Judith, et al.. (2003). Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9. Experimental Hematology. 31(9). 779–783. 63 indexed citations
9.
Szyper‐Kravitz, Martine, Orit Uziel, Hava Shapiro, et al.. (2003). Granulocyte colony‐stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy. British Journal of Haematology. 120(2). 329–336. 26 indexed citations
10.
Drucker, Liat, et al.. (2003). The effects of doxorubicin on apoptosis and adhesion molecules of normal peripheral blood leukocytes—an ex vivo study. Anti-Cancer Drugs. 14(5). 383–389. 6 indexed citations
11.
Drucker, Liat, Orit Uziel, Hava Shapiro, et al.. (2003). Thalidomide Down-Regulates Transcript Levels of GC-Rich Promoter Genes in Multiple Myeloma. Molecular Pharmacology. 64(2). 415–420. 27 indexed citations
12.
Bomstein, Yonit, et al.. (2003). The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia. European Journal Of Haematology. 70(5). 290–295. 17 indexed citations
13.
Shalev, Moshe, et al.. (2001). The Prognostic Value of DNA Ploidy in Small Renal Cell Carcinoma. Pathology - Research and Practice. 197(1). 7–12. 5 indexed citations
14.
15.
Meisel, Simcha, et al.. (1998). Increased Expression of Neutrophil and Monocyte Adhesion Molecules LFA-1 and Mac-1 and Their Ligand ICAM-1 and VLA-4 Throughout the Acute Phase of Myocardial Infarction. Journal of the American College of Cardiology. 31(1). 120–125. 126 indexed citations
16.
Varsano, Shabtai, et al.. (1998). Cytokines Modulate Expression of Cell-Membrane Complement Inhibitory Proteins in Human Lung Cancer Cell Lines. American Journal of Respiratory Cell and Molecular Biology. 19(3). 522–529. 37 indexed citations
17.
Klein, Ami, Ruth Zemer, Yosef Manor, et al.. (1997). Lymphoma with multi gene rearrangement on the level of immunoglobulin heavy chain, light chains, and T‐cell receptor β chain. American Journal of Hematology. 56(4). 219–223. 1 indexed citations
18.
Leytin, Valery, et al.. (1996). Flow Cytometric Analysis of the Platelet Surface Area and Surface Density of Glycoprotein IIb-IIIa of Unactivated Human Platelets of Various Sizes. Biochemical and Biophysical Research Communications. 226(1). 94–100. 18 indexed citations
19.
Varsano, Shabtai, Inna Frolkis, Hava Shapiro, & Dov Ophir. (1996). Human Nasal Epithelium Adsorbs Complement C3‐Related Fragments and Expresses Cell Membrane Complement Regulatory Proteins. The Laryngoscope. 106(5). 599–604. 7 indexed citations
20.
Klein, Ami, Yosef Manor, Valery Leytin, et al.. (1994). B-cell malignancy after low grade T-cell lymphoma. Cancer. 74(1). 164–167. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie Oleksowicz Breakdown of academic impact, for papers by José G. van den Berg Breakdown of academic impact, for papers by Beate M. Rüger Breakdown of academic impact, for papers by Tsukasa Takemura Breakdown of academic impact, for papers by Thomas Karonitsch Breakdown of academic impact, for papers by H. Karel Nieuwenhuis Breakdown of academic impact, for papers by Jie Ding Breakdown of academic impact, for papers by Noreen Fulton Breakdown of academic impact, for papers by Maria Melachrinou Breakdown of academic impact, for papers by Boting Wu
Rankless by CCL
2026